BlueCloudX Donates $25 Million to MENASA Group to Advance Health Equity, Clinical Research and Life Sciences Education

Scholarships, training, certification, and tech will expand clinical research participation, professional development for Middle East, North Africa, South Asia

AUSTIN, TX, UNITED STATES, September 29, 2026 /EINPresswire.com/ — BlueCloudX today announced a $25 million commitment in scholarships, education and technology to MENASA Group, a U.S.-based nonprofit organization working to advance health equity and increase the representation of Middle Eastern, North African and South Asian communities in healthcare and clinical research.

The collaboration brings together MENASA Group’s work in advocacy, research inclusion and healthcare professional development with BlueCloudX’s international health and life sciences technology ecosystem. The initiative is designed to help build pathways for MENASA physicians, hospital systems, healthcare, life sciences professionals and emerging researchers to gain education and credentials, become research-ready, connect with clinical trial
opportunities and participate more fully in the global health and life sciences industry.

MENASA Group has made clinical research representation a central part of its mission, working to address gaps in population-specific research and increase the participation of MENASA communities in clinical trials. The organization also supports the development of research-ready physicians and clinical research sites and advocates for greater demographic visibility and inclusion in healthcare and research policy.

The $25 million commitment is part of BlueCloudX’s Philanthropy for a Purpose^® initiative, which combines education, technology and transnational industry connectivity to help organizations build sustainable healthcare and clinical research capacity.

“This is about much more than providing access to technology or education. It is about providing access to opportunity,” said Al O. Pacino II, Co-Founder and General Manager of BlueCloudX. “MENASA Group is working to address a significant gap in global clinical research: ensuring these communities, their physicians and their patients have a meaningful place in the health and clinical research ecosystem. Together, we can provide education, infrastructure and global connectivity that help turn representation into participation.”

Middle Eastern, North African and South Asian communities represent a substantial global population, yet these populations have historically lacked adequate visibility and representation in clinical research and population-specific drug safety and effectiveness data. With help from BlueCloudX, the MENASA Group is working to change that by developing an ecosystem that connects physicians, investigators, research sites, communities and life
sciences organizations internationally.

Its initiatives include efforts to train and prepare physicians to serve as clinical research investigators, develop research-ready clinical sites, increase community awareness and participation in clinical trials, along with clinical research as a care option, and strengthen connections between MENASA healthcare professionals and research sponsors.

Through the initiative with BlueCloudX, eligible MENASA Group members and participants will have access to resources that may include scholarships for education, training and professional development in healthcare, clinical research and life sciences, clinical research education and certification resources designed to help physicians and healthcare professionals develop the knowledge and credentials needed to participate in research, BlueCloudX technology and digital infrastructure connecting healthcare professionals, investigators, research sites and organizations and connectivity to global health and life sciences stakeholders, including pharmaceutical companies, medical device manufacturers, clinical research organizations, research sites, universities, nonprofits and other industry partners.

The goal is to create a continuum from education and training to research readiness, professional visibility and real-world opportunity. A major focus of the collaboration will be supporting MENASA Group’s efforts to expand the pipeline of physicians and healthcare professionals prepared to participate in clinical research. BlueCloudX technology will provide additional infrastructure to support those efforts, including professional connectivity regulatory efforts for real-time patient and subject protection.

“This partnership gives us the ability to move from advocacy to infrastructure,” said Professor Hadi Danawi, PhD, MPH, Founder, Chair and CEO of MENASA Group. “Greater representation in clinical research requires trained investigators, prepared research sites, engaged communities and meaningful connections to sponsors in locations where, until now, sponsor and site expense has been difficult to overcome. The BlueCloudX commitment will help us build
those pathways and create opportunities for MENASA healthcare professionals and communities around the world.”

The collaboration reflects a shared goal of moving beyond awareness of disparities and creating infrastructure capable of producing measurable change.
By combining MENASA Group’s community relationships, advocacy and growing clinical research network with BlueCloudX’s technology, educational resources and global health and life sciences ecosystem, the organizations aim to increase the number of MENASA professionals who can participate in research while expanding opportunities for MENASA communities to be represented in the studies that shape future medicines and healthcare.

“Talent is everywhere. Opportunity is not,” said Tina Posey, CEO of BlueCloudX. “If we want clinical research to better reflect the people who ultimately use medicines and healthcare products, we have to build the infrastructure that allows more communities to participate. Education, technology and connectivity can help turn that goal into something sustainable.”

About BlueCloudX

BlueCloudX is a global healthcare and clinical research ecosystem providing technology, education, professional connectivity, GDPR and USA privacy and compliance infrastructure to healthcare and life sciences stakeholders around the world. BlueCloudX connects millions of professionals across nearly 200 countries and works with healthcare professionals, research organizations, pharmaceutical and medical device companies, universities, nonprofits and other
stakeholders to improve connectivity and expand access to competencies, research and global professional opportunities.

Through its Philanthropy for a Purpose^® initiative, BlueCloudX works with organizations around the world to provide technology and modern educational resources that strengthen healthcare and life sciences infrastructure and create sustainable professional opportunities.

About MENASA Group

MENASA Group is a U.S.-based 501(c)(3) nonprofit organization dedicated to advancing health equity and increasing the representation and participation of Middle Eastern, North African and South Asian (MENASA) communities in healthcare and clinical research. Founded by Professor Hadi Danawi, PhD, MPH, MENASA Group works to address gaps in healthcare access, clinical research representation and population-specific health data through education, advocacy, professional development, community engagement and research infrastructure.

The organization’s initiatives include developing research-ready physicians and clinical investigators, building a global network of culturally competent research sites, expanding clinical trial education and participation, and connecting MENASA healthcare professionals with research sponsors and global opportunities. MENASA Group also collaborates with healthcare, academic and industry organizations in the United States and internationally to strengthen
research capacity and advance a more inclusive global healthcare ecosystem.

Shannon Wolfson
Global Media Director, BlueCloudX Media
+1 281-536-9360
email us here
Visit us on social media:
LinkedIn

Media gallery

About The Author

Written By: EIN Presswire